Although there was a higher relief rate of postpran- dial discomfort, the average score change did not differ between YIT10347 and placebo in the m-FSSG evalu- ation. Additionally, there was a higher score change for postprandial epigastric pain but no difference in the relief rate between YIT10347 and placebo in the m-FSSG evaluation. Relief rate was greatly influenced by the number of participants with GI symptoms in the “before ingestion” period. For example, 17 and 13 par- ticipants had postprandial epigastric pain symptoms in the YIT10347 and placebo groups, respectively. Many of the participants scored zero for this symptom in the “before ingestion” period, making it difficult to detect a difference in relief rate. However, the average score of the 17 participants with postprandial epigastric pain symptoms in the YIT10347 group changed drastically from 1.18 to 0.18. On the other hand, 32 and 33 par- ticipants had postprandial discomfort symptoms in the YIT10347 and placebo groups, respectively. Because over 80% of all participants had felt this symptom in the “before ingestion” period, the difference in the relief rate was clear.